
WuXi AppTec
WUXAY | OTC
$23.98
-$0.34 (-1.40%)
At close: Nov 16, 2026, 3:58 PM ET
$23.98
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 3:58 PM ET
WuXi AppTec Company Profile
Company profile explainedCompany Profile
WuXi AppTec Co., Ltd. functions as an investment holding entity, globally delivering a wide array of research, development, and manufacturing services. Operating across the People's Republic of China, other parts of Asia, the United States, and Europe, the company plays a crucial role in the discovery, advancement, and production of small molecule pharmaceuticals, as well as cell and gene therapies. The organization's operations are divided into six main segments: WuXi Chemistry, WuXi Testing, WuXi Biology, WuXi ATU, WuXi DDSU, and Additional Services. It provides extensive contract research, development, and manufacturing organization (CRDMO) capabilities, supporting novel drug development from initial discovery phases through to commercial launch. This includes handling various synthetic molecular formats such as small molecules, oligonucleotides, peptides, and complex conjugates. Furthermore, WuXi AppTec offers biological services and solutions, spanning from target identification to candidate selection and progression into clinical trials, alongside integrated testing for drugs and medical devices from preclinical stages to clinical applications. The company also specializes in accelerating cell and gene therapies to market through an end-to-end solution, offers bespoke drug discovery services to pharmaceutical and biotech clients, and conducts clinical research. Founded in 2000, WuXi AppTec Co., Ltd. maintains its headquarters in Shanghai, People's Republic of China.
Key Executives
| Name | Position |
|---|---|
| Ge Li | Co-Founder, Executive Chairman, President & Chief Executive Officer |
| Minzhang Chen | Co-CEO & Executive Director |
| Qing Yang | Co-CEO & Executive Director |
| Ming Shi | Senior Vice President & Chief Financial Officer |
| Zhaohui Zhang | Chief Operating Officer of China, Executive Vice President & Executive Director |
| Feng Zhang | Senior Vice President of API Manufacturing |
| Howard Wu | Senior Vice President of Legal Department & Human Resources Department |
| Ruijia Tang | IR Director |
| Tao Guo | Senior Vice President of RCS IPM |
| Youchu Wang | Senior Vice President of API Early Phase Development |
WuXi AppTec

| Country | China |
| IPO Date | Feb 24, 2021 |
| Industry | Medical - Diagnostics & Research |
| Sector | Healthcare |
| Employees | 33,834 |
| CEO | Ge Li |
Contact Details
288 Fute Zhong Road Shanghai,
SH 200131 China
Stock Details
| Ticker Symbol | WUXAY |
| Exchange | OTC |
| Fiscal Year | n/a |
| Reporting Currency | USD |
| CIK Code | n/a |
| CUSIP Number | 98260P103 |
| ISIN Number | US98260P1030 |
| SIC Code | n/a |
Recent News
- 1 month ago / prnewswire.comWuXi AppTec Earns EcoVadis Gold Medal for Third Consecutive Year, Ranking Among Global Top 5% for Sustainability
- 2 months ago / zacks.comRecent Price Trend in Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) is Your Friend, Here's Why
- 3 months ago / prnewswire.comWuXi AppTec Continues to Reward Shareholders, Further Increasing Interim Dividend to RMB 1.51 Billion
- 3 months ago / zacks.comWuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) Is a Great Choice for 'Trend' Investors, Here's Why
- 3 months ago / zacks.comHere's Why Momentum in Wuxi Apptec Co Ltd. - Sponsored ADR (WUXAY) Should Keep going
Add to Watchlist
Select watchlists to add or remove WUXAY